In 2006, the German Medical Devices Industry grew by 8,7 % to 16 Euro billion. Major force behind this growth was export, which grew by 12,8 %, while the main export countries were EU member states, followed by North America. Domestic growth was disappointing.
Greece, Luxembourg, the Netherlands, Scotland, Spain and Switzerland are the first European countries affected by an increase of the influenza virus. Other countries will follow over the coming weeks and should prepare.
Fortunately, the influenza virus has not swapped over to Germany yet because the country has enough to do with the norovirus which is expected to attack up to one million people during the next weeks. People affected by the virus suffer from strong nausea and diarrhoea that last at least two days.
Siemens Medical Solutions strengthens its diagnostics devision, J&J wins stent patent appeal over Boston Scientific and Medtronic, Leica extends its product range and GE Healthcare cooperates with Ludwig-Maximilian-Universität in Munich as a reference center and strategic partner in developing cell-based assay modes.
A donation of the antibiotic Cipro® (Bayer HealthCare) with a wholesale value of more than US$ 25 million has been given to the non-profit organization MAP (Medical Assistance Programs) who will distribute it to clinics and hospitals in Africa and Latin America, which suffer badly from the lack of essential drugs.
Patients with swallowing difficulties could benefit from the new version of the exakt S Tablet Splitter.
Targeted medication and gentle surgical procedures are the pillars of modern breast cancer therapy, according to participants at this years German Congress of Senology.
Cancer can be tackled with a combination of drug and genetic therapies, so that the effectiveness of individual treatments are enhanced.
Less bleeding complications due to safe citrate anticoagulation.
Affordable, effective and innovative products drive sales.
A new biodegradable solution has stopped bleeding in animals' wounds within seconds, according to a report in the journal Nanomedicine.
Like obesity it is harder to treat than high BP or cholesterol. Now Spanish cardiologists are urging a new approach to patients who smoke.
AstraZeneca has been collaborating with researchers who detected a potential Aurora B inhibitor.
The IMS 2007 Pharmaceutical Market Forecast predicts a 5-6% international growth in the global pharmaceuticals market.
Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…
Although the way adults react to drugs is often not the same for children, there are no special trials to check the suitability for smaller size patients.
A Leicester-based registered charity is facing possible criminal prosecution because of supplying unused medicines to healthcare centres in African countries.
The UK spends more of its healthcare budget on cardiovascular disease than any other country in the EU.
Generating targeting agents for diagnostics, prognostics and radiotherapy, by designing biochemically specific elements in contrast agents to be the targeting molecules attached to and carrying diagnostic or radiotherapeutic molecules to abnormal cells.
AIDS, SARS and now H5NI; just a brief beginning or the end? As the virus moves towards Europe, and millions of birds are slaughtered, interest has risen in a Chinese herb, a patent-sharing controversy and drug stockpiling
USA - The 898-bed Massachusetts General Hospital (MGH) in Boston - Harvard Medical School's biggest teaching hospital - has awarded a $3.4 million contract for 1,365 syringe pumps to Smiths Medical
Currently, five years of treatment with tamoxifen is considered the 'gold-standard' treatment for postmenopausal women with breast cancer. This drug blocks oestrogen, which can help fuel the growth of tumours in some cases.
Paris, France - The explosive growth in demand for drug eluting stents has shaped a market worth more than six billion euros annually.
At over 200 years old, it is also one of the oldest hospitals, yet is classed as one of the most up-to-date institutes in Europe.
Switzerland - Providing heroin addicts methadone or buprenorphine as a treatment for their addiction has led to a decline in the number of new heroin users in Zurich, according to a paper by Carlos Nordt and Rudolf Stohler from the Psychiatric University Hospital, Zurich, published in The Lancet.